Coffee with Coker
Episode 56: Private Equity Deals: Operational Components of the Transaction
- February 6, 2020
Brandt Jewell joins Mark to discuss private equity (PE) deals for healthcare entities and the operational considerations PE firms and medical groups alike should consider during the transaction. Brandt and Mark identify opportunities to discuss during due diligence, medical group optimization opportunities after the deal is complete, and the critical characteristics of attractive provider groups.
We welcome all feedback from our listeners. Please submit questions on any of the topics we discuss or about issues that interest you. You can also recommend topics for future episodes.
- Email us: [email protected]
- Connect with us on LinkedIn: Coker Group Company Page
- Follow us on Twitter: @cokergroup
- Follow us on Instagram: @cokergroup
Brandt and Mark review how to identify opportunities during the due diligence phase of the transaction. The specialty or specialty mix of a medical group is a key decision factor when considering a PE deal because a financial return is the primary objective of that type of deal. They also discuss developing a consistent and scalable infrastructure, the pitfalls of aggregating physician operations, and continuing status quo operations after the agreement.
PE Deal Extras
Senior Vice PresidentContact